Compare TCRT & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCRT | TNON |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4M | 2.8M |
| IPO Year | 2025 | 2021 |
| Metric | TCRT | TNON |
|---|---|---|
| Price | $3.06 | $2.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $44.38 |
| AVG Volume (30 Days) | ★ 12.5M | 277.3K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.66 | ★ 84.90 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,900,000.00 | $3,944,000.00 |
| Revenue This Year | N/A | $46.86 |
| Revenue Next Year | N/A | $63.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 20.35 |
| 52 Week Low | $0.72 | $2.40 |
| 52 Week High | $4.50 | $45.50 |
| Indicator | TCRT | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 68.69 | 36.65 |
| Support Level | $2.98 | $2.40 |
| Resistance Level | $3.25 | $4.18 |
| Average True Range (ATR) | 0.65 | 0.23 |
| MACD | 0.25 | 0.00 |
| Stochastic Oscillator | 63.46 | 5.33 |
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.